Health Care & Life Sciences » Biotechnology | IsoRay Inc.

IsoRay Inc. | Income Statement

Fiscal year is July-June. All values USD Thousands.
2013
2014
2015
2016
2017
2018
Sales/Revenue
4,525.20
4,219.20
4,606.50
4,769.30
4,761.00
5,923
Cost of Goods Sold (COGS) incl. D&A
4,375.10
4,415.60
4,439.10
4,640.10
3,923.00
4,081
Gross Income
150.20
196.50
167.40
129.20
838.00
1,842
SG&A Expense
4,217.40
4,391.70
4,503.60
5,667.40
7,193.00
8,571
EBIT
4,067.30
4,588.20
4,336.20
5,538.30
6,355.00
6,729
Unusual Expense
210.00
1,382.10
374.60
610.30
75.00
-
Non Operating Income/Expense
0.00
0.90
2.20
1.00
-
-
Pretax Income
3,856.60
5,959.10
3,681.10
4,710.80
6,162.00
6,700
Consolidated Net Income
3,856.60
5,959.10
3,681.10
4,710.80
6,162.00
6,700
Net Income
3,856.60
5,959.10
3,681.10
4,710.80
6,162.00
6,700
Net Income After Extraordinaries
3,856.60
5,959.10
3,681.10
4,710.80
6,162.00
6,700
Net Income Available to Common
3,867.20
6,696.10
3,691.70
4,721.40
6,173.00
6,711
EPS (Basic)
0.11
0.16
0.07
0.09
0.11
0.12
Basic Shares Outstanding
34,423.40
42,675.20
54,882.40
55,014.90
55,016.00
55,159
EPS (Diluted)
0.11
0.16
0.07
0.09
0.11
0.12
Diluted Shares Outstanding
34,423.40
42,675.20
54,882.40
55,014.90
55,016.00
55,159
EBITDA
3,296.80
3,798.30
3,641.50
4,871.50
6,213.00
6,570
Non-Operating Interest Income
0.70
12.10
282.70
218.10
118.00
29
Preferred Dividends
10.60
737.00
10.60
10.60
11.00
11

About IsoRay

View Profile
Address
350 Hills Street
Richland Washington 99354
United States
Employees -
Website http://www.isoray.com
Updated 07/08/2019
IsoRay, Inc. is a medical technology company. Though its subsidiary IsoRay Medical, Inc., it develops, manufactures, and sells isotope-based medical products and devices for the treatment of cancer and other malignant diseases. Its product include Cesium-131 (Cs-131), a radioisotope for the treatment of prostate cancer, brain cancer, breast cancer, colorectal cancer, gynecological cancer, lung cancer, liver cancer, ocular melanoma, and pancreatic cancer.

StatInvestor

Privacy Policy
Feedback

© 2024 StatInvestor All Rights Reserved.